| PERIOD ENDING | 31-Aug-09 | 31-Aug-08 | | Total Revenue | 4,906 | 18,626 | | Cost of Revenue | 1,037 | 1,565 | | | Gross Profit | 3,869 | 17,061 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 221 | 140 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 3,648 | 16,921 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (21,046) | (38,397) | | Earnings Before Interest And Taxes | 3,129 | 4,579 | | Interest Expense |
-
|
-
| | Income Before Tax | 3,129 | 4,579 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (17,398) | (21,476) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (17,398) | (21,476) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($17,398) | ($21,476) |
|
0.22% Nasdaq 
Income Statement
